{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:06:01Z","timestamp":1790802361437,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejca.2026.117040","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:25:31Z","timestamp":1789086331000},"page":"117040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating free bacterial DNA as a novel biomarker for monitoring therapy response in patients with advanced pancreatic cancer"],"prefix":"10.1016","volume":"247","author":[{"given":"Sai Agash","family":"Surendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5091-5060","authenticated-orcid":false,"given":"Michael","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Lopez","family":"Incera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-4711","authenticated-orcid":false,"given":"Danmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-2127","authenticated-orcid":false,"given":"Stefan","family":"Boeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Kunzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0754-9034","authenticated-orcid":false,"given":"Steffen","family":"Ormanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2026.117040_bib1","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"11","key":"10.1016\/j.ejca.2026.117040_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11864-021-00895-4","article-title":"Systemic therapy for metastatic pancreatic cancer","volume":"22","author":"Ettrich","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2026.117040_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jama.2019.10232","article-title":"Screening for pancreatic cancer: US preventive services task force reaffirmation recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"Jama"},{"key":"10.1016\/j.ejca.2026.117040_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejrad.2017.04.009","article-title":"Imaging modalities in the diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy","volume":"92","author":"Toft","year":"2017","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.ejca.2026.117040_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(19)30416-9","article-title":"Early detection of pancreatic cancer","volume":"5","author":"Pereira","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ejca.2026.117040_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jamcollsurg.2016.02.009","article-title":"Carbohydrate antigen 19-9 elevation in anatomically resectable, early stage pancreatic cancer is independently associated with decreased overall survival and an indication for neoadjuvant therapy: a national cancer database study","volume":"223","author":"Bergquist","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"6356","key":"10.1016\/j.ejca.2026.117040_bib7","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejca.2026.117040_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ejca.2026.117040_bib9","article-title":"Bacterial lipopolysaccharide as a negative predictor of adjuvant gemcitabine efficacy in pancreatic cancer","volume":"6","author":"Guenther","year":"2022","journal-title":"JNCI Cancer Spectr"},{"issue":"4","key":"10.1016\/j.ejca.2026.117040_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41416-025-03078-2","article-title":"Intratumoral bacterial abundance confers poor response to adjuvant gemcitabine in resected pancreatic cancer patients which is mitigated by postoperative antibiotics","volume":"133","author":"Guenther","year":"2025","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2026.117040_bib11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41416-020-01029-7","article-title":"Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study","volume":"123","author":"Guenther","year":"2020","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2026.117040_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ejca.2026.117040_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41420-023-01397-y","article-title":"Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRAS(G12D) mutated pancreatic cancer in vivo model","volume":"9","author":"Panebianco","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ejca.2026.117040_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13099-016-0103-7","article-title":"Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples","volume":"8","author":"Glassing","year":"2016","journal-title":"Gut Pathog"},{"issue":"11","key":"10.1016\/j.ejca.2026.117040_bib15","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41416-022-01974-5","article-title":"A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma","volume":"127","author":"Zaidi","year":"2022","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.117040_bib16","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1038\/s41467-020-16124-9","article-title":"Ultrasensitive digital quantification of cytokines and bacteria predicts septic shock outcomes","volume":"11","author":"Abas\u0131yan\u0131k","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ejca.2026.117040_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1976953","article-title":"Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy","volume":"10","author":"Yang","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ejca.2026.117040_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2026.1802448","article-title":"Assessment of 16S rRNA sequencing for analysis of circulating microbial DNA in colorectal cancer patients-proof of concept and early changes during experimental chemoimmunotherapy","volume":"17","author":"Sanabria","year":"2026","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.ejca.2026.117040_bib19","article-title":"Microbiome markers of pancreatic cancer based on bacteria-derived extracellular vesicles acquired from blood samples: a retrospective propensity score matching analysis","volume":"10","author":"Kim","year":"2021","journal-title":"Biology (Basel)"},{"issue":"1","key":"10.1016\/j.ejca.2026.117040_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12885-024-12463-8","article-title":"Early detection of pancreatic cancer by liquid biopsy \"PANLIPSY\": a french nation-wide study project","volume":"24","author":"Bardol","year":"2024","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2026.117040_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S2468-1253(20)30330-7","article-title":"Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial","volume":"6","author":"Kunzmann","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2026.117040_bib22","article-title":"Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: a biomarker analysis from the NEOLAP trial (AIO-PAK-0113)","volume":"11","author":"Kimmel","year":"2026","journal-title":"ESMO Gastrointest Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2026.117040_bib23","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00432-018-2746-x","article-title":"POLE gene hotspot mutations in advanced pancreatic cancer","volume":"144","author":"Guenther","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.117040_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000094888","article-title":"Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer","volume":"70","author":"Boeck","year":"2006","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.ejca.2026.117040_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100552","article-title":"Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)","volume":"7","author":"Hartlapp","year":"2022","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.ejca.2026.117040_bib26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/sim.6782","article-title":"Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events.","volume":"35","author":"Pavlou","year":"2016","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.117040_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/cancers12041058","article-title":"The prognostic value of the detection of microbial translocation in the blood of colorectal cancer patients","volume":"12","author":"Messaritakis","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ejca.2026.117040_bib28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","article-title":"Microbiome and anticancer immunosurveillance","volume":"165","author":"Zitvogel","year":"2016","journal-title":"Cell"},{"issue":"6161","key":"10.1016\/j.ejca.2026.117040_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejca.2026.117040_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/2326-6066.CIR-16-0125","article-title":"Macropinocytosis of nab-paclitaxel drives macrophage activation in pancreatic cancer","volume":"5","author":"Cullis","year":"2017","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10.1016\/j.ejca.2026.117040_bib31","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.7150\/thno.92672","article-title":"IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis","volume":"14","author":"Vadevoo","year":"2024","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.ejca.2026.117040_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224656","article-title":"16S rDNA droplet digital PCR for monitoring bacterial DNAemia in bloodstream infections","volume":"14","author":"Ziegler","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejca.2026.117040_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116075","article-title":"Quantification of bacterial DNA in blood using droplet digital PCR: a pilot study","volume":"108","author":"Tedim","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.ejca.2026.117040_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4254","article-title":"Association of antibiotic receipt with survival among patients with metastatic pancreatic ductal adenocarcinoma receiving chemotherapy","volume":"6","author":"Fulop","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492600821X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492600821X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:33:29Z","timestamp":1790800409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492600821X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S095980492600821X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117040","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating free bacterial DNA as a novel biomarker for monitoring therapy response in patients with advanced pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117040"}}